350425 <common-name>(2s,3s,4s,5r)-3,4,5-trihydroxy-6-[5-[2-[[4-(quinolin-2-ylmethoxy)phenoxy]methyl]phenyl]tetrazol-2-yl]oxane-2-carboxylic acid</common-name> <description>(2s,3s,4s,5r)-3,4,5-trihydroxy-6-[5-[2-[[4-(quinolin-2-ylmethoxy)phenoxy]methyl]phenyl]tetrazol-2-yl]oxane-2-carboxylic acid is a chemical compound with the formula C30H27N5O8. With an average molecular weight of 585.60 g/mol, (2s,3s,4s,5r)-3,4,5-trihydroxy-6-[5-[2-[[4-(quinolin-2-ylmethoxy)phenoxy]methyl]phenyl]tetrazol-2-yl]oxane-2-carboxylic acid is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>154699755</pubchem-id> <chemical-formula>C30H27N5O8</chemical-formula> <weight>585.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:29:28Z</created-at> <updated-at type="dateTime">2026-08-31T15:29:28Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1=CC=C2C(=C1)C=CC(=N2)COC3=CC=C(C=C3)OCC4=CC=CC=C4C5=NN(N=N5)C6C(C(C(C(O6)C(=O)O)O)O)O</moldb-smiles> <moldb-formula>C30H27N5O8</moldb-formula> <moldb-inchi>InChI=1S/C30H27N5O8/c36-24-25(37)27(30(39)40)43-29(26(24)38)35-33-28(32-34-35)22-7-3-1-6-18(22)15-41-20-11-13-21(14-12-20)42-16-19-10-9-17-5-2-4-8-23(17)31-19/h1-14,24-27,29,36-38H,15-16H2,(H,39,40)/t24-,25-,26+,27-,29?/m0/s1</moldb-inchi> <moldb-inchikey>KXRLQRIPSYPFMG-FENBJSOMSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">585.1859628</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>3</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346318</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(2s,3s,4s,5r)-3,4,5-trihydroxy-6-[5-[2-[[4-(quinolin-2-ylmethoxy)phenoxy]methyl]phenyl]tetrazol-2-yl]oxane-2-carboxylic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom nil="true"/> <superklass nil="true"/> <klass nil="true"/> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0300730</sync-id> <structure-inchikey>KXRLQRIPSYPFMG-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>8000000000000000000080000200000000000000000000020010010000000000000000004000000020000000810000200400000002000000020000000080000000000002000000000000082000000000002280000000030000020800004000000000000001000000000000000000000000000000010000008000008000000010000400000000000180400000000000000008008000010000000000004040000000000000000000000400000208400000000001000008000800010000000000000000000000000004000000000000000000800000000000000000020010000100000000000000000100004000000c000440000001080002008000000000000000</structure-fingerprint> <structure-pattern-fingerprint>7014c2308d328678c9805b6081b8a6001b80148885052070843d20c28334eacc7c224016138000000100492842c00100056003a450dd3225016e653980a04010c7110c891a90162000901260137203100805c59853611f3340041c62542249040c28052f084c9220600c0680ddb4024d30868072814de50631192c6802591212d24439884ef0820808071254caac0289391d981644649e8b5027082060c0048400d3121390b0c3300a040d60017d3d144ac004038943084818804a304cc8c212a04002a644990b3319808484571152990c410012034050608d730284280093049038499418810b24134a0413d91321c60050043080c2840e510491005218020a</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAArAAAAMAAAAIABBkBoAAAAAwMBBkBoAAAA AwMBBkBoAAAAAwMBBkAoAAAAAwQGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMD AQZAaAAAAAMDAQZAKAAAAAMEB0AoAAAAAwMGAGAAAAACAggAKAAAAAMCBkAo AAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMDAQZAaAAA AAMDAQgAKAAAAAMCBgBgAAAAAgIGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMD AQZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkAoAAAAAwQHQCgAAAADAwdA KAAAAAMDB0AoAAAAAwMHQCgAAAADAwYAYAAAAAMBBgBgAAAAAwEGAGAAAAAD AQYAYAAAAAMBBgBgAAAAAwEIACAAAAACBgAoAAAAAwQIACgAAAADAggAaAAA AAMBAQgAYAAAAAEBCABgAAAAAQEIAGAAAAABAQsAAWgMAQJoDAIDaAwDBGgM BAVoDAQGaAwGB2gMBwhoDAgJaAwICgAKCwALDCAMDWgMDQ5oDA4PaAwPEGgM EBFoDA8SIBITABMUABQVaAwVFmgMFhdoDBcYaAwYGWgMGRogGhtoDBscaAwc HWgMHR5oDBwfAB8gACAhACEiACIjACMkACMlACUmKAIlJyAiKAAhKQAgKgAF AGgMCQNoDBEMaAwZFGgMHhpoDCQfAEIGAAAABgAFBAMCAQYGBwgJAwQGDQ4P EBEMBhUWFxgZFAUbGh4dHAYgISIjJB8XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:24Z</structure-indexed-at> </compound>